More than half of the companies in the NSE 500 index are currently trading at least 30% below their all-time peak levels, with many stocks continuing to hit fresh lows. This is occurring even as the ...
HeartBeam, Inc. (NASDAQ:BEAT) announced Thursday that it received a Not Substantially Equivalent (NSE) letter from the U.S. Food and Drug Administration regarding its 510(k) application for its ...
In Space Warlord Baby Trading Simulator, you of course do not actually trade BABIES. We aren’t monsters. You buy stocks BASED on the simulated lives of babies, profiting from their misery and cashing ...
Shares of NSE listed Balaxi Pharmaceuticals Limited surged nearly 10 per cent on Friday, November 21, 2025 even as benchmark indices Sensex and Nifty remained volatile after declining in early trade ...
Hosted on MSN
HeartBeam (NASDAQ: BEAT) Outlines Regulatory Strategy After NSE Decision on ECG Synthesis Software
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
In a move that reflects India’s rapidly maturing market infrastructure, the National Stock Exchange (NSE) empanelled Tradetron as an authorised algo-trading technology provider, adding further ...
(MENAFN- Investor Brand Network) HeartBeam (NASDAQ: BEAT), a medical technology company developing personalized cardiac-care insights, detailed its strategy following receipt of a Not Substantially ...
Sudeep Pharma shares settled over 30 percent higher from its initial public offer (IPO) price on the debut day at Rs 771.85 per share on the National Stock Exchange (NSE) on Friday. The stock finished ...
Family Bank CEO and MD Nancy Njau (centre) during a breakfast meeting at a Nairobi Hotel on November 25, 2025. [Kanyiri Wahito] Family Bank said on Tuesday it plans to list on the Nairobi Securities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results